Drug intelligence / Profile preview

Agiolax Micro

Development stage
Unknown
Lead developer
MADAUS
Modality
Small Molecules
Administration
Oral
01

Overview

Agiolax Micro is a plant-derived combination laxative developed by Madaus GmbH. It consists of psyllium (Plantago ovata) seeds and husks, which act as a bulk-forming agent, and Tinnevelly senna fruits (Senna alexandrina), which serve as a stimulant laxative. The Micro formulation refers to a microgranule presentation of the standard Agiolax product line. It has been investigated under the name Agio-Prep as a bowel preparation agent prior to colonoscopy, where it was compared against standard polyethylene glycol-based preparations like Moviprep in Phase 3 clinical trials. The mechanism involves increasing stool volume and water retention via psyllium while stimulating colonic motility through the action of sennosides on the intestinal mucosa and enteric nervous system.

Brand names
Agiolax MicroAgiolax
Other names
psyllium + sennaPlantago ovata + Senna alexandrina

Beyond the preview

Go deeper on Agiolax Micro.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Agiolax Micro.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call